Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3926 | 508 | 23.9 | 35% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
198 | 48841 | CELLULAR IMMUNOLOGY//THYMOSIN BETA 4//INTERLEUKIN 2 |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
25144 | 241 | ANTITUMOR RESISTANCE//ANTITUMOR IMMUNIZATION//RE KAVETSKY EXPT PATHOL ONCOL RADIOBIOL |
26476 | 208 | UKRAIN//CHELIDONIUM//ADJUNCT MEMBER |
34887 | 59 | STRUCTURAL LEVELS//A STRUCTURAL PHENOMENOLOGICAL CONCEPTION//LYMPHOMA U 937 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | UKRAIN | Author keyword | 28 | 81% | 3% | 17 |
2 | ANTITUMOR RESISTANCE | Author keyword | 5 | 60% | 1% | 6 |
3 | RE KAVETSKY EXPT PATHOL ONCOL RADIOBIOL | Address | 2 | 11% | 4% | 20 |
4 | ANTITUMOR IMMUNIZATION | Author keyword | 2 | 67% | 0% | 2 |
5 | ANTITUMOR VACCINE | Author keyword | 2 | 43% | 1% | 3 |
6 | CYTOSUPPRESSION | Author keyword | 1 | 100% | 0% | 2 |
7 | IMMUNOLOGICAL REACTION KINETICS | Author keyword | 1 | 100% | 0% | 2 |
8 | TOTAL PROTEOLYTIC ACTIVITY | Author keyword | 1 | 100% | 0% | 2 |
9 | LEWIS CARCINOMA | Author keyword | 1 | 33% | 1% | 3 |
10 | CHELIDONIUM | Author keyword | 1 | 33% | 0% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | UKRAIN | 28 | 81% | 3% | 17 | Search UKRAIN | Search UKRAIN |
2 | ANTITUMOR RESISTANCE | 5 | 60% | 1% | 6 | Search ANTITUMOR+RESISTANCE | Search ANTITUMOR+RESISTANCE |
3 | ANTITUMOR IMMUNIZATION | 2 | 67% | 0% | 2 | Search ANTITUMOR+IMMUNIZATION | Search ANTITUMOR+IMMUNIZATION |
4 | ANTITUMOR VACCINE | 2 | 43% | 1% | 3 | Search ANTITUMOR+VACCINE | Search ANTITUMOR+VACCINE |
5 | CYTOSUPPRESSION | 1 | 100% | 0% | 2 | Search CYTOSUPPRESSION | Search CYTOSUPPRESSION |
6 | IMMUNOLOGICAL REACTION KINETICS | 1 | 100% | 0% | 2 | Search IMMUNOLOGICAL+REACTION+KINETICS | Search IMMUNOLOGICAL+REACTION+KINETICS |
7 | TOTAL PROTEOLYTIC ACTIVITY | 1 | 100% | 0% | 2 | Search TOTAL+PROTEOLYTIC+ACTIVITY | Search TOTAL+PROTEOLYTIC+ACTIVITY |
8 | LEWIS CARCINOMA | 1 | 33% | 1% | 3 | Search LEWIS+CARCINOMA | Search LEWIS+CARCINOMA |
9 | CHELIDONIUM | 1 | 33% | 0% | 2 | Search CHELIDONIUM | Search CHELIDONIUM |
10 | AMIXIN | 1 | 50% | 0% | 1 | Search AMIXIN | Search AMIXIN |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MAJUS L UKRAIN | 14 | 100% | 1% | 7 |
2 | NSC 631570 | 14 | 100% | 1% | 7 |
3 | DRUG UKRAIN | 6 | 80% | 1% | 4 |
4 | INTERMITTENT 3 MONTH TREATMENT | 6 | 80% | 1% | 4 |
5 | UKRAIN | 3 | 50% | 1% | 5 |
6 | ACID ALKALOID DERIVATIVES | 1 | 100% | 0% | 2 |
7 | 3 MONTH TREATMENT | 0 | 20% | 0% | 2 |
8 | RAS GENE FAMILY | 0 | 33% | 0% | 1 |
9 | DISSECTING KARYOTYPIC PATTERNS | 0 | 25% | 0% | 1 |
10 | TREATED BREAST CANCER | 0 | 25% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Ukrain - a new cancer cure? A systematic review of randomised clinical trials | 2005 | 22 | 117 | 86% |
Ukrain: A novel antitumor drug | 2000 | 9 | 30 | 83% |
Advantages of Nanotechnology- Based Chinese Herb Drugs on Biological Activities | 2009 | 5 | 64 | 8% |
Cellular basis of cancer metastasis: A review of fundamentals and new advances | 2006 | 32 | 29 | 3% |
Connecting mitotic instability and chromosome aberrations in cancer - can telomeres bridge the gap? | 2005 | 37 | 55 | 2% |
The human genome project: a historical perspective | 2001 | 5 | 30 | 3% |
Effect of environmental nitric oxides on the antitumor resistance of rats | 2005 | 1 | 24 | 4% |
Terrestrial plant-derived anticancer agents and plant species used in anticancer research | 2006 | 15 | 195 | 2% |
Scientists and clinicians test their metal-back to the future with platinum compounds | 2002 | 14 | 77 | 1% |
AGE ASPECTS OF IRON TRANSPORT AND UTILIZATION | 1982 | 0 | 3 | 33% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RE KAVETSKY EXPT PATHOL ONCOL RADIOBIOL | 2 | 11% | 3.9% | 20 |
2 | ADJUNCT MEMBER | 1 | 50% | 0.2% | 1 |
3 | CHAIR CONSERVAT DENT | 1 | 50% | 0.2% | 1 |
4 | FUNDACAO MUSEU HOMEM AMER | 1 | 50% | 0.2% | 1 |
5 | SIBERIAN TOMSK | 1 | 50% | 0.2% | 1 |
6 | TRANSLAT SAFETY BIOMARKERS | 1 | 50% | 0.2% | 1 |
7 | SOFT TISSUE BONE SARCOMAS | 0 | 33% | 0.2% | 1 |
8 | ALL RUSSIAN EMERGENCY RADIAT MED | 0 | 25% | 0.2% | 1 |
9 | CHEM DYNAM GEOSPHERE ICG PHYTOSPHERE 3 | 0 | 25% | 0.2% | 1 |
10 | PROGRAMA ANTROPOL | 0 | 25% | 0.2% | 1 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000020828 | TUMOR DORMANCY//DORN VA MED//CONCOMITANT RESISTANCE |
2 | 0.0000016671 | JOURNAL OF THE RETICULOENDOTHELIAL SOCIETY//MANNOSE RECEPTOR//ENDO180 |
3 | 0.0000011792 | P15E//IMMUNE SUPPRESSOR CELLS//IRX 2 |
4 | 0.0000009065 | INTERLEUKIN 2//GRANZYME B//PERFORIN |
5 | 0.0000008873 | VESTNIK DERMATOLOGII I VENEROLOGII//BRCN ACTIVATED SEPHAROSE//CURANTIL |
6 | 0.0000008616 | TIME & SOCIETY//NONSTANDARD WORK SCHEDULES//TIMESCAPE |
7 | 0.0000008567 | IMEXON//LEVAMISOLE//TYROSERLEUTIDE |
8 | 0.0000008445 | TERPENOPHENOLS//2 ISOBORNYL 4 METHYLPHENOL//EXPERIMENTAL GESTOSIS |
9 | 0.0000007899 | SPARC//GROWTH DIFFERENTIATION FACTOR 15//GDF 15 |
10 | 0.0000007233 | BERBERINE//AMARYLLIDACEAE ALKALOIDS//SANGUINARINE |